Abstract
The old idea of the blood purification of a diseased body has acquired a new sense and real possibilities over the last two decades. There are at least two sources for this phenomenon: deeper insights into pathological processes of diseases based on rapid progress in biochemistry, immunology and the genetic sciences, and the development of numerous separation techniques also suitable for blood constituents, particularly for plasma components. A straightforward line can be seen from separation techniques such as plasmapheresis/plasma exchange over cryofiltration, cascade filtration methods and the use of broad-based adsorbents such as charcoal up to the development of selective and specific adsorbents for the binding of only a few components or even one certain plasma constituent. The selective and/or specific removal of pathologically relevant components without any influence on other plasma substances is the aim of a modern plasma treatment therapy. For these purposes, various adsorbents have been developed. Table 1 gives examples of specific immunoadsorbents acting on the principle of the antigen-antibody reaction. (For the research groups see references.) Work in Rostock has involved investigations relating to the development of selective adsorbents. This publication describes aspects of this research.
This is a preview of subscription content, log in via an institution.
Preview
Unable to display preview. Download preview PDF.
References
Behm, E., Kuroda, T., Yamawaki, N., Tsuda, N., Loth, F., Schwachula, G., Sabrowski, E., Falkenhagen, D. and Klinkmann, H. (1987a). In vitro investigations with selective adsorbents for IgE and IgM. Biomaterials, Artificial Cells, and Artificial Organs, 15(1), 101–111.
Behm, E., Toewe, D., Kuroda, T., Yamawaki, N., Tsuda, S., Ernst, B. and Klinkmann, H. (1987b). Binding of lipids by a newly developed synthetic material. 1st Int. Congr. Wld Apheresis Ass., Tokyo, Japan, in press.
Bensinger, W. I., Baker, D. A., Buckner, C. D., Clift, R. A. and Thomas, E. D. (1981). Immunoadsorption for removal of A and B blood-group antibodies. New Engl J. Med., 304, 160–162.
Björk, L. and Kronvall, G. (1984). Purification and some properties of streptococcal protein G, a novel IgG binding reagent. J. Immun., 133, 969–974.
Borberg, H., Bode, C., Mattele, L., Oette, K., Taucher, M. and Stoffel, W. (1983). LDL-apheresis in hypercholesterolemic patients: technical and clinical aspects, in M. J. Lysaght and H. J. Gurland (eds), Plasma Separation and Plasma Fractionation, Karger, Basel, pp. 266–271.
Forsgren, A., Ghetie, V., Lindmark, R. and Sjöquist, J. (1983). Protein A and its exploitation, in C. S. F. Easmon and C. Adlam (eds), Staphylococci and Staphylococcal Infections 2, Academic Press, London, pp. 429–480.
Kuroda, T., Okamoto, T., Yokoyama, T., Yamawaki, N., Inagaki, K., Umegae, M., Yokoyama, S. and Yamamoto, A. (1987). High capacity adsorbent of low density lipoprotein (LDL) for plasmapheresis. 1st Int. Congr. Wld Apheresis Ass., Tokyo, Japan, in press.
Langone, J. J. (1982). Protein A of Staphylococcus aureus and related immunoglobulin receptors produced by streptococci and pneumococci. Adv. Immun., 32, 157–252.
Nilsson, I. M., Sundquist, S.-B., Ljung, R., Holmberg, L., Freiburghaus, C. and Björlin, G. (1983). Suppression of secondary antibody response by intravenous immunoglobulin in a patient with haemophilia B and antibodies. Scand. J. Haematol., 30, 458–464.
Odaka, M., Kobayashi, H., Tabata, Y., Soeda, K., Hayashi, H., Ito, S., Murotani, N., Saito, Y., Nishide, Y., Shinomiya, M. and Yoshida, S. (1987). Long term results of LDL selective plasma adsorption therapy of familial hypercholesterolemia. Biomaterials, Artificial Cells and Artificial Organs, 15(1), 113–124.
Reis, K. J., Ayoub, E. M. and Boyle, M. D. P. (1984a). Streptococcal Fc receptors. I. Isolation and partial characterization of the receptor from a group C streptococcus. J. Immun., 132, 3091–3096.
Reis, K. J., Ayoub, E. M. and Boyle, M. D. P. (1984b). Streptococcal Fc receptors. II. Comparison of the reactivity of a receptor from a group C streptococcus with staphylococcal protein A. J. Immun., 132, 3098–3102.
Sato, T., Nishimiya, J., Arai, K., Anno, M., Yamawaki, N., Kuroda, T. and Inagaki, K. (1983). Selective removal of anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis in vitro with a new immunoadsorbent, in T. Oda (ed.), Therapeutic Plasmapheresis III, Schattauer Verlag, Stuttgart, pp. 565–568.
Stoffel, W. and Bode, C. (1984). Selective removal of low density lipoproteins, in A. A. Pineda (ed.), Selective Plasma Component Removal, Futura Publ. Co., Mount Kisco, New York, pp. 1–22.
Terman, D. S., Buffaloe, G., Mattioli, C., Cook, G., Tilquist, R., Sullivan, M. and Ayus, J. C. (1979). Extracorporeal immunoadsorption: initial experience in human systemic lupus erythematosus. Lancet, II, 824–827.
Traeger, J., Laville, M., El Habib, R., Moskovtchenko, J. F., Coulet, P. R. and Gautheron, D. C. (1983). Extracorporeal immunoadsorption of DNA-antibodies on DNA-coated collagen films: first results in systemic lupus erythematosus, in Y. Nosé, P. S. Malchesky and J. W. Smith (eds), Plasmapheresis: New Trends in Therapeutic Applications, ISAO Press, Cleveland, OH, pp, 155–166.
Tsuruta, Y., Maeda, K., Shinzato, T., Sezaki, R., Usuda, M., Yamada, K., Obayashi, S., Saito, A., Ohta, K., Yamawaki, N., Kuroda, T. and Inagaki, K. (1983). Clinical application of improved 1–02 immunosorbent column, in Y. Nosé, P. S. Malchesky and J. W. Smith (eds), Plasmapheresis: New Trends in Therapeutic Applications, ISAO Press, Cleveland, OH, pp. 149–154.
Yamazaki, Z., Fujimori, Y., Iizoka, I., Kanai, F., Takahama, T., Wada, T., Asano, K., Yoshizawa, H., Takahashi, Y., Ogita, T., Inoue, N., Yamawaki, N., Inagaki, K. and Tsuda, N. (1984). Immunosorbent plasma perfusion in patients with rheumatoid arthritis or systemic lupus erythematosus. Progr. artif. Organs, No. 204, Vol. 2, 708–712.
Yokoyama, S., Hayashi, R., Kikkawa, T., Tani, N., Takada, S., Hatanaka, K. and Yamamoto, A. (1984). Specific sorbent of apolipoprotein B-containing lipoproteins for plasmapheresis. Arteriosclerosis, 4, 276–282.
Yokoyama, S., Hayashi, R., Satani, M. and Yamamoto, A. (1985). Selective removal of low density lipoproteins by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis, 5, 613–622.
Editor information
Copyright information
© 1988 Bioengineering Unit, University of Strathclyde
About this chapter
Cite this chapter
Behm, E., Falkenhagen, D., Klinkmann, H., Courtney, J.M. (1988). Novel Approaches to Blood Purification. In: Paul, J.P., McCruden, A.B., Schuetz, P.W. (eds) The Influence of New Technology on Medical Practice. Keynes Seminars. Palgrave, London. https://doi.org/10.1007/978-1-349-09609-1_13
Download citation
DOI: https://doi.org/10.1007/978-1-349-09609-1_13
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-09611-4
Online ISBN: 978-1-349-09609-1
eBook Packages: EngineeringEngineering (R0)